Use of 18-cyano-progesterone derivatives as aldosterone inhibitors
申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0380135A2
公开(公告)日:1990-08-01
The present invention is directed to a method for the treatment of hyperaldosteronism and related disorders which comprises administering to an appropriate patient an appropriate 18-cyanopregnane.